Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enanta Pharmaceutica (NQ: ENTA ) 10.95 -0.30 (-2.67%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enanta Pharmaceutica < Previous 1 2 3 4 5 6 7 Next > A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts October 09, 2024 Via Benzinga Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study September 26, 2024 Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms while maintaining a favorable safety profile. EDP-323 offers potential as a... Via Benzinga Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV) September 26, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Participate in Investor Conferences in September September 03, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Recap: Enanta Pharma Q1 Earnings February 07, 2024 Via Benzinga Earnings Scheduled For February 7, 2024 February 07, 2024 Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. Via Benzinga ENTA Stock Earnings: Enanta Pharma Beats EPS, Beats Revenue for Q3 2024 August 05, 2024 ENTA stock results show that Enanta Pharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. Via InvestorPlace Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter August 05, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference May 29, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference May 07, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Earnings Preview For Enanta Pharma February 06, 2024 Via Benzinga Enanta Pharmaceuticals Inc. (NASDAQ: ENTA) Near the Top of Equities by Percentage Gain on 11/21 November 21, 2023 Via Investor Brand Network ENTA Stock Earnings: Enanta Pharma Misses EPS, Beats Revenue for Q2 2024 May 06, 2024 ENTA stock results show that Enanta Pharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET May 06, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 30, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire What 5 Analyst Ratings Have To Say About Enanta Pharma November 21, 2023 Via Benzinga Recap: Enanta Pharma Q4 Earnings November 20, 2023 Via Benzinga Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer April 30, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024 April 29, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024 April 17, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference March 06, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET February 07, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference February 06, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023 January 31, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference January 04, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference November 22, 2023 From Enanta Pharmaceuticals, Inc. Via Business Wire Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 21, 2023 Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the... Via Benzinga Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET November 20, 2023 From Enanta Pharmaceuticals, Inc. Via Business Wire Earnings Scheduled For November 20, 2023 November 20, 2023 Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million. Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
